<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="letter"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Protein Cell</journal-id><journal-id journal-id-type="iso-abbrev">Protein Cell</journal-id><journal-id journal-id-type="publisher-id">proteincell</journal-id><journal-title-group><journal-title>Protein &#x00026; Cell</journal-title></journal-title-group><issn pub-type="ppub">1674-800X</issn><issn pub-type="epub">1674-8018</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39225378</article-id><article-id pub-id-type="pmc">PMC11786721</article-id><article-id pub-id-type="doi">10.1093/procel/pwae048</article-id><article-id pub-id-type="publisher-id">pwae048</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letters</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI00960</subject></subj-group></article-categories><title-group><article-title>RADICAL: a rationally designed ion channel activated by ligand for chemogenetics</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0620-7638</contrib-id><name><surname>Zhang</surname><given-names>Heng</given-names></name><aff>
<institution>Liangzhu Laboratory, Zhejiang University Medical Center</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff><aff>
<institution>Kidney Disease Center of the First Affiliated Hospital and Department of Biophysics, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff><xref rid="fn-0001" ref-type="author-notes"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7237-3541</contrib-id><name><surname>Zheng</surname><given-names>Zhiwei</given-names></name><aff>
<institution>Department of Neurobiology, Department of Neurology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 310058</addr-line>, <country country="CN">China</country></aff><aff>
<institution>NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Research and Brain&#x02013;Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University</institution>, <addr-line>Hangzhou 310058</addr-line>, <country country="CN">China</country></aff><xref rid="fn-0001" ref-type="author-notes"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8779-2263</contrib-id><name><surname>Chen</surname><given-names>Xiaoying</given-names></name><aff>
<institution>Liangzhu Laboratory, Zhejiang University Medical Center</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff><aff>
<institution>Kidney Disease Center of the First Affiliated Hospital and Department of Biophysics, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Lizhen</given-names></name><aff>
<institution>Liangzhu Laboratory, Zhejiang University Medical Center</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff><aff>
<institution>Kidney Disease Center of the First Affiliated Hospital and Department of Biophysics, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Chen</given-names></name><aff>
<institution>Department of Neurobiology, Department of Neurology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 310058</addr-line>, <country country="CN">China</country></aff><aff>
<institution>NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Research and Brain&#x02013;Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University</institution>, <addr-line>Hangzhou 310058</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jiawei</given-names></name><aff>
<institution>Liangzhu Laboratory, Zhejiang University Medical Center</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff><aff>
<institution>Kidney Disease Center of the First Affiliated Hospital and Department of Biophysics, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7362-6237</contrib-id><name><surname>Cui</surname><given-names>Yihui</given-names></name><aff>
<institution>Department of Neurobiology, Department of Neurology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 310058</addr-line>, <country country="CN">China</country></aff><aff>
<institution>NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Research and Brain&#x02013;Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University</institution>, <addr-line>Hangzhou 310058</addr-line>, <country country="CN">China</country></aff><xref rid="c1" ref-type="corresp"/><!--yihuicui@zju.edu.cn--></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0520-5254</contrib-id><name><surname>Yang</surname><given-names>Fan</given-names></name><aff>
<institution>Liangzhu Laboratory, Zhejiang University Medical Center</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff><aff>
<institution>Kidney Disease Center of the First Affiliated Hospital and Department of Biophysics, Zhejiang University School of Medicine</institution>, <addr-line>Hangzhou 311121</addr-line>, <country country="CN">China</country></aff><xref rid="c2" ref-type="corresp"/><!--fanyanga@zju.edu.cn--></contrib></contrib-group><author-notes><fn id="fn-0001"><p>Heng Zhang and Zhiwei Zheng contributed equally to this work.</p></fn><corresp id="c1">Correspondence: <email>yihuicui@zju.edu.cn</email></corresp><corresp id="c2">Correspondence: <email>fanyanga@zju.edu.cn</email></corresp></author-notes><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-09-03"><day>03</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>03</day><month>9</month><year>2024</year></pub-date><volume>16</volume><issue>2</issue><fpage>136</fpage><lpage>142</lpage><history><date date-type="received"><day>22</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2024</year></date><date date-type="corrected-typeset"><day>20</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="pwae048.pdf"/><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="DOI">10.13039/501100001809</institution-id></institution-wrap>
</funding-source><award-id>32122040</award-id><award-id>31971040</award-id><award-id>32071017</award-id><award-id>31922031</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Zhejiang Provincial Natural Science Foundation of China</institution></institution-wrap>
</funding-source><award-id>LR20C050002</award-id></award-group></funding-group><counts><page-count count="6"/></counts></article-meta></front><body><sec id="s1"><title>Dear Editor,</title><p>Manipulating neuronal activities by exogenous means is always much desired in the field of neuroscience and beyond. Though many optogenetics and chemogenetics tools, such as channelrhodopsins and DREADDs (<xref rid="CIT0001" ref-type="bibr">Armbruster et al., 2007</xref>; <xref rid="CIT0012" ref-type="bibr">Sternson and Roth, 2014</xref>), have been developed and widely used, there are several limitations in these tools. For optogenetics, the invasiveness of implanted optical fiber is unavoidable. For chemogenetics, the DREADDs are G-protein coupled receptors that rely on complex cellular signaling networks to indirectly modulate ion channels to influence neuronal activity (<xref rid="CIT0001" ref-type="bibr">Armbruster et al., 2007</xref>), therefore, their pharmacokinetics are slow (<xref rid="CIT0004" ref-type="bibr">Lerchner et al., 2007</xref>). Chemogenetic tools that utilize engineered chimeric ligand-gated ion channels, like the nicotinic acetylcholine receptor (nAChR), are designed to modify neuronal excitability directly (<xref rid="CIT0005" ref-type="bibr">Magnus et al., 2011</xref>). However, since the nAChR is abundantly expressed in the brain, how the subunits in the engineered nAChR interact with the endogenous subunits, as well as the potential effects of these interactions, remain to be investigated. Therefore, a noninvasive chemogenetic tool that directly manipulates neuronal potential with little endogenous expression of its native form in the brain is needed.</p><p>To develop such a chemogenetic tool, we targeted the transient receptor potential melastatin 8 (TRPM8), which is a calcium-permeable ion channel with limited expression regions in the brain (<xref rid="CIT0003" ref-type="bibr">Jang et al., 2012</xref>; <xref rid="CIT0006" ref-type="bibr">McKemy et al., 2002</xref>; <xref rid="CIT0007" ref-type="bibr">Mohandass et al., 2020</xref>; <xref rid="CIT0010" ref-type="bibr">Peier et al., 2002</xref>). We rationally designed a mutant TRPM8 channel to be activated by the chemical cyclohexanol (CHXOL) (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). CHXOL is analogous to the classic TRPM8 agonist menthol, but it lacks the isopropyl and methyl groups as compared to menthol (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). CHXOL (1&#x02013;3 mmol/L) did not affect activities of a range of ion channels including hERG and many TRP channels (<xref rid="sup1" ref-type="supplementary-material">Fig. S1</xref>). Furthermore, CHXOL did not alter the resting membrane potential (RMP) or action potential in neurons and brain slices of mice (<xref rid="sup1" ref-type="supplementary-material">Fig. S2</xref>). As we found that the interaction between isopropyl group in menthol and residue I846 in TRPM8 is essential for binding (<xref rid="F1" ref-type="fig">Fig. 1B</xref>) (<xref rid="CIT0015" ref-type="bibr">Xu et al., 2020</xref>), CHXOL lacking this group did not bind well with TRPM8 as the top 10 scored CHXOL binding models with best binding energy were highly diversified in their binding configuration as shown in the molecular docking (<xref rid="F1" ref-type="fig">Fig. 1B</xref>).</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Engineering of TRPM8 channel to be activated by CHXOL and more sensitive to CHXOL. (A) The approach to engineer the TRPM8 channel to respond to CHXOL. (B) Upper left panel, the structure of menthol and CHXOL. Upper right and bottom panels, comparison of docking of menthol to wild type TRPM8, CHXOL to WT TRPM8, and CHXOL to TRPM8 I846F mutant. (C and D) Energies of VDW interactions in Rosetta energy unit (R.E.U.) and the root mean square deviation (RMSD) between CHXOL and TRPM8 or I846F mutant (<italic toggle="yes">n</italic>&#x02005;=&#x02005;10). E, energy. Data were shown as mean&#x02005;&#x000b1;&#x02005;S.E.M. Unpaired two-sided <italic toggle="yes">t</italic>-test was used to analyze statistical significance. (E) Whole-cell patch-clamp recordings of WT TRPM8 channels in response to CHOXL at the membrane potential of &#x000b1;80 mV. (F) Concentration&#x02013;response of CHOXL on TRPM8 I846F mutant at &#x000b1;80 mV. (G) Concentration&#x02013;response curve of CHOXL on TRPM8 I846F mutant (<italic toggle="yes">n</italic>&#x02005;=&#x02005;7). (H) Top panel, calcium imaging of HEK293T cells expressing WT TRPM8 channels in response to CHXOL, menthol or 10 &#x003bc;mol/L ionomycin. Bottom panel, calcium imaging of HEK293T cells expressing I846F mutant in response to CHXOL or 10 &#x003bc;mol/L ionomycin, scale bar&#x02005;=&#x02005;25 &#x003bc;m. Asterisks represent cells with a significant increase in intracellular calcium. (I) The normalized fluorescence intensity of HEK293T cells expressing WT TRPM8 channels (<italic toggle="yes">n</italic>&#x02005;=&#x02005;14). (J) The normalized fluorescence intensity of HEK293T cells expressing I846F mutant (<italic toggle="yes">n</italic>&#x02005;=&#x02005;8). (K) Representative currents elicited by a voltage step protocol (inset) in the presence or absence of 5 mmol/L CHXOL recorded from HEK293 cells expressing WT TRPM8 or TRPM8 mutants. (L) Normalized G-V curves for WT TRPM8 or TRPM8 mutants in the absence and presence of CHXOL (<italic toggle="yes">n</italic>&#x02005;=&#x02005;4&#x02013;11). Boltzmann equation was used to fit the G&#x02013;V relationship. (M) Bar graph of <italic toggle="yes">V</italic><sub>1/2</sub> values calculated from panel (L) for WT TRPM8 or TRPM8 mutants in the absence and presence of CHXOL (<italic toggle="yes">n</italic>&#x02005;=&#x02005;4&#x02013;11; *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.05 by one way ANOA). (N) Top panel, the concentration&#x02013;response of CHOXL on I846F-I985K mutant at &#x02212;80 mV. Bottom panel, representative current traces of I846F-I985K mutant activated by CHOXL from the top panel. (O) Representative single-channel current traces of I985K-I846F mutant in the bath and in the presence of 0.1 mmol/L CHXOL were recorded at &#x02212;80 mV. O and C indicate open and closed states, respectively. (P) Calcium imaging of HEK293T cells expressing I846F-I985K mutant in response to CHXOL or ionomycin, scale bar&#x02005;=&#x02005;25 &#x003bc;m. (Q) The normalized fluorescence intensity of HEK293T cells expressing I846F-I985K mutant (<italic toggle="yes">n</italic> = 19). (R&#x02013;T) Representative the current of TRPM8 and I846F-I985K mutants in extracellular perfusion of 145 mmol/L NaCl, KCl, NMDG or 100 mmol/L NMDG + 30 mmol/L CaCl<sub>2</sub>. Voltage ramps were used to generate current&#x02013;voltage curves. (U) Ion permeability ratio was calculated from reversal potentials in panel (R&#x02013;T) (<italic toggle="yes">n</italic>&#x02005;=&#x02005;3&#x02013;6).</p></caption><graphic xlink:href="pwae048_fig1" position="float"/></fig><p>CHXOL cannot activate the wildtype TRPM8 even at a high concentration of 10 mmol/L in patch-clamp recordings (<xref rid="F1" ref-type="fig">Fig. 1E</xref>). Therefore, we hypothesized that by increasing the sidechain bulkiness in I846, binding of CHXOL to TRPM8 mutant can be re-established to open the mutant channel. To test this hypothesis, we first docked CHXOL to the TRPM8-I846F mutant with a bulky sidechain. We observed that the top 10 scored models of CHXOL exhibited better convergence and larger binding energy (<xref rid="F1" ref-type="fig">Fig. 1B&#x02013;D</xref>). Indeed, in patch-clamp recordings, we found CHXOL concentration-dependently activated TRPM8-I846F with the EC<sub>50</sub> of 1.13 &#x000b1; 0.07 mmol/L (<xref rid="F1" ref-type="fig">Fig. 1F</xref> and <xref rid="F1" ref-type="fig">1G</xref>). On the other hand, when residue I846 was mutated to residues with smaller side chains such as glycine (G, no side chain), alanine (A), and leucine (L), the mutated channels could not respond to CHXOL (<xref rid="sup1" ref-type="supplementary-material">Fig. S3</xref>).</p><p>However, as the current elicited by CHXOL at hyperpolarizing membrane potential of &#x02212;80 mV was small (<xref rid="F1" ref-type="fig">Fig. 1F</xref>), we further performed calcium imaging to test whether CHXOL can induce calcium influx. We observed that 1 mmol/L CHXOL indeed elicited calcium influx in cells expressing TRPM8-I846F (<xref rid="F1" ref-type="fig">Fig. 1H</xref> and <xref rid="F1" ref-type="fig">1J</xref>), while no such increase in intracellular calcium was observed by CHXOL in cells expressing the wildtype TRPM8 (<xref rid="F1" ref-type="fig">Fig. 1H</xref> and <xref rid="F1" ref-type="fig">1I</xref>). These results suggested we indeed engineered a TRPM8 mutant to respond to CHXOL as we designed.</p><p>To further improve the CHXOL sensitivity in TRPM8-I846F at the physiologically relevant hyperpolarizing membrane potential, we introduced the I985K mutation to TRPM8-I846F as this mutation enhances the voltage sensitivity of TRPM8 (<xref rid="CIT0014" ref-type="bibr">Taberner et al., 2014</xref>). As expected, the G&#x02013;V curve of I846F-I985K mutant showed a dramatic left shift with half-maximal activation voltage (<italic toggle="yes">V</italic><sub>1/2</sub>) of 117.2 &#x000b1; 13.2 mV as compared with WT (208.2 &#x000b1; 3.4 mV) or I846F mutant (152.4 &#x000b1; 10.8 mV). And the addition of CHXOL decreased the <italic toggle="yes">V</italic><sub>1/2</sub> to 123.6 &#x000b1; 13.5 mV for I846F mutant and 91.9 &#x000b1; 13.7 mV for I985K-I846F (<xref rid="F1" ref-type="fig">Fig. 1K&#x02013;M</xref>). As a result, the TRPM8-I846F-I985K double mutant exhibited a much larger current activated by CHXOL at &#x02212;80 mV (<xref rid="F1" ref-type="fig">Fig. 1N</xref>). Though the EC<sub>50</sub> to CHXOL on TRPM8-I846F-I985K double mutant remains unchanged at +80 mV (1.17 &#x000b1; 0.11 mmol/L) as compared to TRPM8-I846F mutant, these results suggested that the introduction of I985K indeed enhanced the voltage sensitivity in this channel. In single-channel recordings, CHXOL also elicited opening events in the double mutant at &#x02212;80 mV (<xref rid="F1" ref-type="fig">Fig. 1O</xref>). In calcium imaging, 100 &#x000b5;mol/L CHXOL, which barely induced calcium influx with TRPM8-I846F, elicited robust calcium signal in cells transfected with TRPM8-I846F-I985K mutant (<xref rid="F1" ref-type="fig">Fig. 1P</xref> and <xref rid="F1" ref-type="fig">1Q</xref>). Moreover, prolonged exposure of CHXOL over 50 s almost decreased the intracellular calcium fluorescence to baseline (<xref rid="sup1" ref-type="supplementary-material">Fig. S4A</xref> and <xref rid="sup1" ref-type="supplementary-material">S4B</xref>). Such a decrease in calcium fluorescence was not due to photobleaching of the loaded Fluo-4 AM dyes because we observed a higher fluorescence intensity upon the application of ionomycin. In addition, the presence of 3 mmol/L CHXOL did not increase the cell death ratio in HEK293T cells expressing WT TRPM8 channels or I846F-I985K mutants (<xref rid="sup1" ref-type="supplementary-material">Fig. S4C</xref> and <xref rid="sup1" ref-type="supplementary-material">S4D</xref>), indicating the extent of CHXOL-induced activation of the rationally designed ion channel activated by ligand (RADICAL) was insufficient to induce cell death. These results suggested the influx of calcium was controllable and the amount of Ca<sup>2+</sup> influx was limited. Moreover, the calcium selectivity of the TRPM8-I846F-I985K mutant was maintained as the wildtype TRPM8 channel (<xref rid="F1" ref-type="fig">Fig. 1R&#x02013;U</xref>).</p><p>We further test the ligand activation and temperature activation on the TRPM8-I846F-I985K mutant. I846F-I985K mutant and WT TRPM8 showed similar response to icilin with EC50 of 53.8 &#x000b1; 15.3 nmol/L and 51.4 &#x000b1; 12.9 nmol/L, respectively (<xref rid="sup1" ref-type="supplementary-material">Fig. S5A</xref> and <xref rid="sup1" ref-type="supplementary-material">S5B</xref>). In addition, we also calculated the change of enthalpic (&#x00394;<italic toggle="yes">H</italic>) and entropic (&#x00394;<italic toggle="yes">S</italic>) due to the temperature-driven transition of the TRPM8 channel. &#x00394;<italic toggle="yes">H</italic> and &#x00394;<italic toggle="yes">S</italic> exhibited similar behavior among WT TRPM8, I846F and I846F-I985K mutants, suggesting the temperature-related property of RADICAL remains unchanged (<xref rid="sup1" ref-type="supplementary-material">Fig. S5D</xref>&#x02013;<xref rid="sup1" ref-type="supplementary-material">G</xref>).</p><p>We next employed virus-based delivery techniques to assess the <italic toggle="yes">in vivo</italic> effects of activating the CHXOL-TRPM8 mutant system in mice. We used lentivirus, which allows packaging of plasmid with 4.5&#x02013;6 bp in length, together with the human synapsin promoter to deliver eGFP tagged mutant TRPM8 channel specifically in neurons (both pLenti-hSyn-TRPM8 (I846F) and pLenti-hSyn-TRPM8 (I846F-I985K)) (<xref rid="sup1" ref-type="supplementary-material">Fig. S6</xref>). We chose to express the virus in the infralimbic cortex (IL) (<xref rid="sup1" ref-type="supplementary-material">Fig. S7</xref>), which is necessary for the retrieval of fear memory extinction in rodents (<xref rid="CIT0002" ref-type="bibr">Duvarci and Pare, 2014</xref>; <xref rid="CIT0009" ref-type="bibr">Orsini and Maren, 2012</xref>). Twenty-one days after bilateral injection into the IL, pLenti-mediated viral transfection led to the expression of mTRPM8 (I846F) in neurons throughout the IL (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). To confirm the efficacy of the CHXOL-mTRPM8 I846F mutant system, we performed whole-cell patch clamp recordings from virally transfected IL neurons (<xref rid="F2" ref-type="fig">Fig. 2B&#x02013;I</xref>). We found that while 0.1 mmol/L CHXOL did not affect any physiological characteristics of the viral transfected neurons (<xref rid="F2" ref-type="fig">Fig. 2B&#x02013;E</xref>), 1 mmol/L CHXOL depolarized RMP, increased the intrinsic excitability on pLenti-hSyn-TRPM8 (I846F) transfected neurons (<xref rid="F2" ref-type="fig">Fig. 2F&#x02013;I</xref>).</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>Activation of the CHXOL-TRPM8 system in infralimbic cortex neurons and ventral tegmental area (VTA) astrocytes by viral injection enhanced retrieval of fear extinction memory and locomotor behavior in mice, respectively. (A) Illustration (top) and a representative image (bottom) of viral delivery in IL. (B&#x02013;E) Electrophysiological results of 0.1 mmol/L CHXOL on I846F-mutant expressing IL neurons. (B) RMP, <italic toggle="yes">n</italic>&#x02005;=&#x02005;13, mice&#x02005;=&#x02005;7, Paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic>&#x02005;=&#x02005;0.0728; (C) spontaneous activity, <italic toggle="yes">n</italic>&#x02005;=&#x02005;13, mice&#x02005;=&#x02005;7, Paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic>&#x02005;=&#x02005;0.3370; (D) Raw traces showed voltage responses to a series of 500 ms current pulses from 0 to 200 pA with 20-pA steps; (E) number of induced APs with 20-pA current steps, <italic toggle="yes">n</italic>&#x02005;=&#x02005;13, mice&#x02005;=&#x02005;7, Paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic>&#x02005;=&#x02005;0.0977. (F&#x02013;G) Statistics show significant depolarization effects of 1 mmol/L CHXOL on resting membrane potential (RMP) (F, <italic toggle="yes">n</italic>&#x02005;=&#x02005;12, mice&#x02005;=&#x02005;7, Paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic>&#x02005;=&#x02005;0.0055, <italic toggle="yes">t</italic>&#x02005;=&#x02005;3.447, df&#x02005;=&#x02005;11) but not on the spontaneous activity (G, <italic toggle="yes">n</italic>&#x02005;=&#x02005;12, mice&#x02005;=&#x02005;7, Paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic>&#x02005;=&#x02005;0.1820, <italic toggle="yes">t</italic>&#x02005;=&#x02005;1.425, df&#x02005;=&#x02005;11) in I846F-mutant expressing mice. (H&#x02013;I), Current&#x02013;voltage relationship before and during 1 mmol/L CHXOL perfusion. Raw traces of panel H showed voltage responses to a series of 500 ms current pulses from 0 to 200 pA with 20-pA steps. The number of induced APs with 20-pA current steps was significantly increased after CHXOL perfusion (I, <italic toggle="yes">n</italic> = 11, mice = 7, paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic> = 0.0001, <italic toggle="yes">t</italic> = 5.964, df = 10). (J) Experimental design. Mice fear conditioned to three tone-shock pairings (0.6 mA/2-s shock) on day 1; extinction on day 2; CHXOL or saline administration 30 min before extinction test on day 2; retrieval test on day 3. (K&#x02013;O) 10 mg/kg CHXOL showed no effect on extinction retrieval (<italic toggle="yes">n</italic> = 8&#x02013;10; Fear acquisition test, One-way ANOVA, <italic toggle="yes">P</italic> = 0.5795, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant+CHXOL)</sub> = 0.3729, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.3729; extinction test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.1563, <italic toggle="yes">F</italic>(2, 12) = 2.176, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant+CHXOL)</sub> = 0.0623, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.2062; extinction retrieval test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.8901, <italic toggle="yes">F</italic>(2, 12) = 0.1176, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant+CHXOL)</sub> = 0.6494, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub>&#x02005;=&#x02005;0.9084; open field test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.4121, <italic toggle="yes">F</italic>(2, 12) = 0.9552, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant + CHXOL)</sub>&#x02005;=&#x02005;0.8347, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.2216). (P&#x02013;T) 100 mg/kg CHXOL activation of I846F-mutant-expressing IL during extinction training did not affect the expression of freezing but facilitated extinction retrieval on the following day without altering locomotion in an open-field test (<italic toggle="yes">n</italic> = 8&#x02013;10; fear acquisition test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.5555, <italic toggle="yes">F</italic>(2, 24) = 0.6025, <italic toggle="yes">P</italic><sub>(I846F-mutant + saline vs I846F-mutant + CHXOL)</sub> = 0.5612, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-mutant + CHXOL)</sub> = 0.6507; extinction test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.2204, <italic toggle="yes">F</italic>(2, 24) = 1.612, <italic toggle="yes">P</italic><sub>(I846F-mutant + saline vs I846F-mutant + CHXOL)</sub> = 0.0871, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-mutant + CHXOL)</sub> = 0.4323; extinction retrieval test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.0427, <italic toggle="yes">F</italic>(2, 24) = 3.605, <italic toggle="yes">P</italic><sub>(I846F-mutant + saline vs I846F-mutant + CHXOL)</sub> = 0.0230, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-mutant + CHXOL)</sub> = 0.0319; open field test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.2385, <italic toggle="yes">F</italic>(2, 30) = 1.504, <italic toggle="yes">P</italic><sub>(I846F-mutant+saline vs I846F-mutant+CHXOL)</sub> = 0.3378, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-mutant + CHXOL)</sub> = 0.0940). (U) Illustration (top) and a representative image (bottom) of viral delivery in IL. (V and W) Statistics show significant depolarization effects of CHXOL (0.1 mmol/L) on RMP (V, <italic toggle="yes">n</italic> = 12, mice = 3, Paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic> = 0.0022, <italic toggle="yes">t</italic> = 3.963, df = 11) and the spontaneous activity (W, <italic toggle="yes">n</italic> = 12, mice = 3, Wilcoxon test, <italic toggle="yes">P</italic> = 0.0312, <italic toggle="yes">W</italic> = 21) in I846F-I985K-mutant expressing mice. (X and Y) Current&#x02013;voltage relationship before and during 0.1 mmol/L CHXOL perfusion. Raw traces showed voltage responses to a series of 500 ms current pulses from 0 to 200 pA with 20-pA steps. Green and yellow traces indicate APs induced by 100 pA and 120 pA injected current. The number of induced APs with 20-pA current steps was significantly increased after CHXOL perfusion (Y, <italic toggle="yes">n</italic> = 9, mice = 3, Paired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic> &#x0003c; 0.0001, <italic toggle="yes">t</italic> = 8.099, df = 10). (Z-AE) Experimental design. Mice fear conditioned to three tone-shock pairings (0.6 mA/2-s shock) on day 1; extinction on day 2; 10 mg/kg CHXOL or saline administration 30 min before extinction test on day 2; retrieval test on day 3. (Z, mice<sub>I846F-(I985K)-mutant + saline</sub> = 10, mice<sub>control virus + CHXOL</sub> = 10, mice<sub>I846F-(I985K)-mutant + CHXOL</sub> = 10; AA&#x02013;AC, mice<sub>I846F-(I985K)-mutant + saline</sub> = 9, mice<sub>control virus + CHXOL</sub> = 10, mice<sub>I846F-(I985K)-mutant + CHXOL</sub> = 10). AD&#x02013;AE, CHXOL activation of I846F-I985K-mutant-expressing IL during extinction training did not affect the expression of freezing but facilitated extinction retrieval at the following day without altering locomotion in the open-field test (fear acquisition test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.2994, <italic toggle="yes">F</italic>(2, 27) = 1.261, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.1788, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.1817; extinction test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.9230, <italic toggle="yes">F</italic>(2, 26) = 0.08042, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.8710, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.8123; extinction retrieval test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.0514, <italic toggle="yes">F</italic>(2, 26) = 3.335, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.0403, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.0304; open field test, one-way ANOVA, <italic toggle="yes">P</italic> = 0.3780, <italic toggle="yes">F</italic>(2, 26) = 1.010, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.1864, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.7729). (AF) Schematic of the experimental design for testing locomotion in mice that express mTRPM8 (I846F-I985K) in VTA astrocytes, scale bar = 500 &#x000b5;m. (AG) Representative examples of locomotion in the open-field test (OFT). (AH) Statistics of total distance traveled in OFT 30 min after i.p. CHXOL or saline injection in mice which were injected with pLenti-mTRPM8 (I846F-I985K) or its control virus in VTA (OFT, <italic toggle="yes">n</italic>&#x02005;=&#x02005;8 mice for each group, one-way ANOVA, <italic toggle="yes">P</italic> = 0.0003, <italic toggle="yes">F</italic> = 12.42, <italic toggle="yes">P</italic><sub>(I846F-(I985K)-mutant + saline vs I846F-(I985K)-mutant + CHXOL)</sub> = 0.0003, <italic toggle="yes">P</italic><sub>(control virus + CHXOL vs. I846F-(I985K)-mutant + CHXOL)</sub> = 0.004).</p></caption><graphic xlink:href="pwae048_fig2" position="float"><alt-text>(AF) Schematic of the experimental design for testing locomotion in mice that express mTRPM8 (I846F-I985K) in VTA astrocytes, scale bar = 500 &#x000b5;m.</alt-text></graphic></fig><p>To assess if <italic toggle="yes">in vivo</italic> activation of the CHXOL-TRPM8 (I846F) system affects IL-related behavioral consequences, we injected CHXOL (i.p. 10 mg/kg and 100 mg/kg) or the vehicle control in mice expressing pLenti-hSyn-TRPM8 (I846F). As expected, in the fear conditioning test (<xref rid="F2" ref-type="fig">Fig. 2J&#x02013;T</xref>), activation of IL TRPM8 (I846F) transfected neurons by 100 mg/kg but not 10 mg/kg CHXOL enhanced the retrieval of fear extinction memory without affecting locomotion levels compared to the virus and vehicle controls (<xref rid="F2" ref-type="fig">Fig. 2J&#x02013;T</xref>).</p><p>As the TRPM8-I846F-I985K double mutant exhibits a higher sensitivity to CHXOL (<xref rid="F1" ref-type="fig">Fig. 1N&#x02013;Q</xref>), we further tested the <italic toggle="yes">in vivo</italic> efficacy of pLenti-hSyn-TRPM8 (I846F-I985K) system (<xref rid="F2" ref-type="fig">Fig. 2U</xref>). We found that a much lower concentration of CHXOL (0.1 mmol/L) significantly depolarized RMP, increased the intrinsic excitability on pLenti-hSyn-TRPM8 (I846F-I985K) transfected neurons (<xref rid="F2" ref-type="fig">Fig. 2V&#x02013;Y</xref>). In the fear conditioning test (<xref rid="F2" ref-type="fig">Fig. 2Z</xref>), a lower concentration of 10 mg/kg CHXOL significantly enhanced the retrieval of extinction memory of TRPM8 (I846F-I985K) mice compared to the virus and vehicle controls (<xref rid="F2" ref-type="fig">Fig. 2AA&#x02013;AE</xref>).</p><p>Furthermore, we also tested the <italic toggle="yes">in vivo</italic> efficacy of RADICAL in glial cells in the ventral tegmental area (VTA). The astrocytes in VTA played a central role in the control of locomotor activity (<xref rid="CIT0011" ref-type="bibr">Requie et al., 2022</xref>). We used lentivirus, together with the astrocyte-specific GfaABC1D promoter to deliver mCherry tagged mutant TRPM8 channel specifically in VTA astrocytes. After bilateral VTA injection of pLenti-GfaABC1D-mCherry-P2A-mTRPM8 (I846F-I985K)-WPRE virus, locomotion of mice was tested (<xref rid="F2" ref-type="fig">Fig. 2AF</xref>). As we expected, 10 mg/kg CHXOL induced locomotor hyperactivity in TRPM8 (I846F-I985K) mice as compared to control mice (<xref rid="F2" ref-type="fig">Fig. 2AG&#x02013;AH</xref>).</p><p>Therefore, we have developed a rationally designed ion channel activated by ligand (RADICAL) for chemogenetics manipulation of animal behaviors. As RADICAL is based on calcium permeable TRPM8-I846F-I985K mutant, neuronal processes where elevation of intracellular calcium level is involved, such as learning and memory, can be tuned by this tool. TRPM8 channel is barely expressed in the brain (<xref rid="CIT0003" ref-type="bibr">Jang et al., 2012</xref>; <xref rid="CIT0006" ref-type="bibr">McKemy et al., 2002</xref>; <xref rid="CIT0010" ref-type="bibr">Peier et al., 2002</xref>), so virus injection and expression of our RADICAL tool in the brain are expected to less perturb the subunit assembly and physiological function of endogenous ion channels.</p><p>Though our RADICAL is currently hosted on a lentiviral vector, such a system is compatible with the Cre recombinase (<xref rid="CIT0008" ref-type="bibr">Nie et al., 2018</xref>; <xref rid="CIT0013" ref-type="bibr">Sumegi et al., 2012</xref>). It is feasible to specifically express RADICAL in different cell types of Cre mice. We acknowledge that due to the size of RADICAL being too large, it cannot be packaged into an adeno-associated virus (AAV) vector so the application of the current version of RADICAL may be partially limited. Therefore, to broaden the usage of RADICAL we are dedicated to engineer an improved version of this chemogenetics tool in future, which can be packaged into an AAV vector by decreasing the size of TRPM8 without changing its channel activity.</p></sec><sec id="s2" sec-type="supplementary-material"><title>Supplementary data</title><p>Supplementary data is available at <ext-link xlink:href="https://doi.org/10.1093/procel/pwae048" ext-link-type="uri">https://doi.org/10.1093/procel/pwae048</ext-link>.</p><supplementary-material id="sup1" position="float" content-type="local-data"><label>pwae048_suppl_Supplementary_Materials</label><media xlink:href="pwae048_suppl_supplementary_materials.pdf"/></supplementary-material></sec></body><back><sec id="s3"><title>Footnotes</title><p>We are grateful to Ms Yiqin Liu of Zhejiang University and our lab members for their assistance and discussion.</p><p>H.Z., X.C., L.X., and J.W. conducted the <italic toggle="yes">in vitro</italic> experiments including patch-clamp recordings, calcium imaging and molecular docking; Z.W. and C.G conducted animal behavior experiments and patch-clamp recordings on brain slices. F.Y. and Y.C. conceived and supervised the project and prepared the manuscript; H.Z., Z.W., Y.C. and F.Y. participated in data analysis and manuscript writing.</p><p>The authors declare no conflicts of interest.</p><p>This work was supported by funding from the National Natural Science Foundation of China (32122040 and 31971040 to F.Y.; 32071017 and 31922031 to Y.C.); Zhejiang Provincial Natural Science Foundation of China (LR20C050002 to F.Y.); China Postdoctoral Program for Innovative Talents (BX20230323 to H.Z.); China Postdoctoral Science Foundation (2024M752858 to H.Z.); The Fundamental Research Funds for the Central Universities (226-2022-00227 to F.Y.; 226-2022-00149 to Y.C.); Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions (NYKFKT2019001 to Y.C.); The Fundamental Research Funds for the Central Universities (226-2022-00227 to F.Y.).</p><p>All animal studies and experimental procedures were approved by the Animal Care and Use Committee of the animal facility at Zhejiang University. Informed consents were obtained from all the authors. The authors declare their agreement to publish.</p><p>All data needed to evaluate the conclusions in the paper are presented in the paper. Additional data is available from authors upon request.</p></sec><ref-list id="r1"><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Armbruster</surname>
<given-names>BN</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Pausch</surname><given-names>MH</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2007</year>;<volume>104</volume>:<fpage>5163</fpage>&#x02013;<lpage>5168</lpage>.<pub-id pub-id-type="pmid">17360345</pub-id>
</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Duvarci</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Pare</surname><given-names>D.</given-names></string-name></person-group>
<article-title>Amygdala microcircuits controlling learned fear</article-title>. <source>Neuron</source><year>2014</year>;<volume>82</volume>:<fpage>966</fpage>&#x02013;<lpage>980</lpage>.<pub-id pub-id-type="pmid">24908482</pub-id>
</mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jang</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Kim</surname><given-names>SM</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Quantitative analysis of TRP channel genes in mouse organs</article-title>. <source>Arch Pharm Res</source><year>2012</year>;<volume>35</volume>:<fpage>1823</fpage>&#x02013;<lpage>1830</lpage>.<pub-id pub-id-type="pmid">23139135</pub-id>
</mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lerchner</surname>
<given-names>W</given-names>
</string-name>, <string-name><surname>Xiao</surname><given-names>C</given-names></string-name>, <string-name><surname>Nashmi</surname><given-names>R</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl-channel</article-title>. <source>Neuron</source><year>2007</year>;<volume>54</volume>:<fpage>35</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">17408576</pub-id>
</mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Magnus</surname>
<given-names>CJ</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>PH</given-names></string-name>, <string-name><surname>Atasoy</surname><given-names>D</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Chemical and genetic engineering of selective ion channel</article-title>&#x02013;<article-title>ligand interactions</article-title>. <source>Science</source><year>2011</year>;<volume>333</volume>:<fpage>1292</fpage>&#x02013;<lpage>1296</lpage>.</mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>McKemy</surname>
<given-names>DD</given-names>
</string-name>, <string-name><surname>Neuhausser</surname><given-names>WM</given-names></string-name>, <string-name><surname>Julius</surname><given-names>D.</given-names></string-name></person-group>
<article-title>Identification of a cold receptor reveals a general role for TRP channels in thermosensation</article-title>. <source>Nature</source><year>2002</year>;<volume>416</volume>:<fpage>52</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">11882888</pub-id>
</mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mohandass</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Krishnan</surname><given-names>V</given-names></string-name>, <string-name><surname>Gribkova</surname><given-names>ED</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>TRPM8 as the rapid testosterone signaling receptor: implications in the regulation of dimorphic sexual and social behaviors</article-title>. <source>FASEB J</source><year>2020</year>;<volume>34</volume>:<fpage>10887</fpage>&#x02013;<lpage>10906</lpage>.<pub-id pub-id-type="pmid">32609392</pub-id>
</mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nie</surname>
<given-names>X</given-names>
</string-name>, <string-name><surname>Kitaoka</surname><given-names>S</given-names></string-name>, <string-name><surname>Tanaka</surname><given-names>K</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>The innate immune receptors TLR2/4 mediate repeated social defeat stress-induced social avoidance through prefrontal microglial activation</article-title>. <source>Neuron</source><year>2018</year>;<volume>99</volume>:<fpage>464</fpage>&#x02013;<lpage>479.e7</lpage>.<pub-id pub-id-type="pmid">30033154</pub-id>
</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Orsini</surname>
<given-names>CA</given-names>
</string-name>, <string-name><surname>Maren</surname><given-names>S.</given-names></string-name></person-group>
<article-title>Neural and cellular mechanisms of fear and extinction memory formation</article-title>. <source>Neurosci Biobehav Rev</source><year>2012</year>;<volume>36</volume>:<fpage>1773</fpage>&#x02013;<lpage>1802</lpage>.<pub-id pub-id-type="pmid">22230704</pub-id>
</mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Peier</surname>
<given-names>AM</given-names>
</string-name>, <string-name><surname>Moqrich</surname><given-names>A</given-names></string-name>, <string-name><surname>Hergarden</surname><given-names>AC</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>A TRP channel that senses cold stimuli and menthol</article-title>. <source>Cell</source><year>2002</year>;<volume>108</volume>:<fpage>705</fpage>&#x02013;<lpage>715</lpage>.<pub-id pub-id-type="pmid">11893340</pub-id>
</mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Requie</surname>
<given-names>LM</given-names>
</string-name>, <string-name><surname>Gomez-Gonzalo</surname><given-names>M</given-names></string-name>, <string-name><surname>Speggiorin</surname><given-names>M</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Astrocytes mediate long-lasting synaptic regulation of ventral tegmental area dopamine neurons</article-title>. <source>Nat Neurosci</source><year>2022</year>;<volume>25</volume>:<fpage>1639</fpage>&#x02013;<lpage>1650</lpage>.<pub-id pub-id-type="pmid">36396976</pub-id>
</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sternson</surname>
<given-names>SM</given-names>
</string-name>, <string-name><surname>Roth</surname><given-names>BL.</given-names></string-name></person-group>
<article-title>Chemogenetic tools to interrogate brain functions</article-title>. <source>Annu Rev Neurosci</source><year>2014</year>;<volume>37</volume>:<fpage>387</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="pmid">25002280</pub-id>
</mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sumegi</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Fukazawa</surname><given-names>Y</given-names></string-name>, <string-name><surname>Matsui</surname><given-names>K</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Virus-mediated swapping of zolpidem-insensitive with zolpidem-sensitive GABA(A) receptors in cortical pyramidal cells</article-title>. <source>J Physiol</source><year>2012</year>;<volume>590</volume>:<fpage>1517</fpage>&#x02013;<lpage>1534</lpage>.<pub-id pub-id-type="pmid">22351636</pub-id>
</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Taberner</surname>
<given-names>FJ</given-names>
</string-name>, <string-name><surname>Lopez-Cordoba</surname><given-names>A</given-names></string-name>, <string-name><surname>Fernandez-Ballester</surname><given-names>G</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>The region adjacent to the C-end of the inner gate in transient receptor potential melastatin 8 (TRPM8) channels plays a central role in allosteric channel activation</article-title>. <source>J Biol Chem</source><year>2014</year>;<volume>289</volume>:<fpage>28579</fpage>&#x02013;<lpage>28594</lpage>.<pub-id pub-id-type="pmid">25157108</pub-id>
</mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Han</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Molecular mechanisms underlying menthol binding and activation of TRPM8 ion channel</article-title>. <source>Nat Commun</source><year>2020</year>;<volume>11</volume>:<fpage>3790</fpage>.<pub-id pub-id-type="pmid">32728032</pub-id>
</mixed-citation></ref></ref-list></back></article>